Flamel Technologies SA (NASDAQ:FLML)
| 14.96 Data as of 3:59pm ET |  +0.09 / +0.61%Today’s Change | 5.30 Today|||52-Week Range 15.75 | +85.84% Year-to-Date |
Latest FLML News | Press Releases
| Mondaybs Top Biotech Stories: MannKind, Dicerna, Flamel, and Merck Jun 30 / MotleyFool.com | 3 Biotech Stocks with Jaw-Dropping Growth Potential Jun 27 / MotleyFool.com |
Today’s Trading
| Previous close | 14.87 |
| Today’s open | 14.90 |
| Day’s range | 14.50 - 14.98 |
| Volume | 113,063 |
| Average volume (3 months) | 225,849 |
| Market cap | $569.0M |
| Dividend yield | -- |
Data as of 3:59pm ET, 07/11/2014
Growth & Valuation
| Earnings growth (last year) | -1,200.92% |
| Earnings growth (this year) | +64.50% |
| Earnings growth (next 5 years) | +136.00% |
| Revenue growth (last year) | -13.92% |
| P/E ratio | NM |
| Price/Sales | 9.12 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRTAProthena Corporation... | -0.30 | -1.43% |
| INFIInfinity Pharmaceuti... | +0.45 | +3.95% |
| MGNXMacroGenics Inc | +0.29 | +1.46% |
| VTLVital Therapies Inc | -0.22 | -0.94% |
Data as of 4:00pm ET, 07/11/2014
Financials
| Next reporting date | July 28, 2014 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $22.5M |
| Annual profit (last year) | -$43.0M |
| Net profit margin | -191.26% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters --, -- |
Forecasts
.
